Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Auffret

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|April 1, 2014
Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance databaseJohana Béné, Guillaume Moulis, Marine Auffret, et al.
Frontiers in Pharmacology|August 7, 2024
NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysisMarie-Lou Dessus-Gilbert, Mikail Nourredine, Luc Zimmer, et al.
International Journal of Clinical Pharmacy|February 11, 2015
Attitudes of community pharmacists to off-label prescribing of baclofen in Northern FranceMarine Auffret, Benjamin Rolland, Anne-Sylvie Caous, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 4, 2025
Safety of ifosfamide during pregnancy: A comprehensive analysisCharlotte Devant, Tessa Pietri, Marine Auffret, et al.
International Clinical Psychopharmacology|October 31, 2014
Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort studyBenjamin Rolland, Thomas Valin, Carole Langlois, et al.
Joint Bone Spine|September 18, 2025
Temporal evolution of publication bias in drug safety assessment: A case study on association between osteonecrosis of the jaw and bisphosphonatesNimetullah Aksoy, Guillaume Grenet, Maëlys Granal, et al.
Human Psychopharmacology|May 19, 2017
The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort studyBaptiste Pignon, Julien Labreuche, Marine Auffret, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2015
Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedationBenjamin Rolland, Julien Labreuche, Alain Duhamel, et al.
Fundamental & Clinical Pharmacology|February 24, 2026
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024Cécile Chevallier, Anne Batisse, Emilie Monzon, et al.
CNS Drugs|June 14, 2026
Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase<sup>®</sup> DataPauline Schiro, Mónica Gálvez Pacoricona, Adèle Le Guilloux, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|April 1, 2014
Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance databaseJohana Béné, Guillaume Moulis, Marine Auffret, et al.
Frontiers in Pharmacology|August 7, 2024
NMDA antagonist agents for the treatment of symptoms in autism spectrum disorder: a systematic review and meta-analysisMarie-Lou Dessus-Gilbert, Mikail Nourredine, Luc Zimmer, et al.
International Journal of Clinical Pharmacy|February 11, 2015
Attitudes of community pharmacists to off-label prescribing of baclofen in Northern FranceMarine Auffret, Benjamin Rolland, Anne-Sylvie Caous, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|May 4, 2025
Safety of ifosfamide during pregnancy: A comprehensive analysisCharlotte Devant, Tessa Pietri, Marine Auffret, et al.
International Clinical Psychopharmacology|October 31, 2014
Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort studyBenjamin Rolland, Thomas Valin, Carole Langlois, et al.
Joint Bone Spine|September 18, 2025
Temporal evolution of publication bias in drug safety assessment: A case study on association between osteonecrosis of the jaw and bisphosphonatesNimetullah Aksoy, Guillaume Grenet, Maëlys Granal, et al.
Human Psychopharmacology|May 19, 2017
The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort studyBaptiste Pignon, Julien Labreuche, Marine Auffret, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2015
Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedationBenjamin Rolland, Julien Labreuche, Alain Duhamel, et al.
Fundamental & Clinical Pharmacology|February 24, 2026
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024Cécile Chevallier, Anne Batisse, Emilie Monzon, et al.
CNS Drugs|June 14, 2026
Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase<sup>®</sup> DataPauline Schiro, Mónica Gálvez Pacoricona, Adèle Le Guilloux, et al.
Pageof 4